3,883
edits
Changes
Volunteer Assignments and Opportunities (view source)
Revision as of 13:18, 7 August 2020
, 13:18, 7 August 2020no edit summary
|-
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author (Target Completion Date)'''!!'''Associate Editor'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content Pending or Complete'''
!'''Author Content Pending or Complete'''
!'''Date Completed by Author'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Editor Reviewed (Date of Last Review)'''
!'''Date of Last Editor Review'''
!'''Notes'''
!'''Notes'''
|-
|-
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|Fabiola Quintero-Rivera (FQR)
|
|PENDING
|PENDING
|
|
|Fabiola Quintero-Rivera (FQR)
|
|
|
|
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
|Gokce A. Toruner
|Gokce A. Toruner
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
|T. Niroshi Senaratne
|T. Niroshi Senaratne
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
|Rebecca Smith (trainee) + faculty TBD
|Rebecca Smith (trainee) + faculty TBD
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
|Mark Evans (trainee), Fabiola Quintero-Rivera
|Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
|Mark Evans (trainee)+ Fabiola Quintero-Rivera
|Mark Evans (trainee)+ Fabiola Quintero-Rivera
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
|-
|-
|'''''Mastocytosis'''''||'''''Overview'''''||
|'''''Mastocytosis'''''||'''''Overview'''''||
|
|
|
|
|
| ||FQR
|
|
|
|
|Thuy Phung
|Thuy Phung
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
|Shashi Shetty
|Shashi Shetty
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
|Thuy Phung
|Thuy Phung
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
| Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden (trainee) +Daynna J.Wolff
| Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden (trainee) +Daynna J.Wolff
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
| Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
| Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
| Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
| Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
| Myeloid/Lymphoid Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
| Myeloid/Lymphoid Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
|Lauren R. Crowson (trainee) + Daynna J. Wolff
|Lauren R. Crowson (trainee) + Daynna J. Wolff
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
| Chronic Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
| Chronic Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
| Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
| Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
| Juvenile Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
| Juvenile Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
| Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
| Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
| Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
| Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
|
|
|
|
|
|
|
|FQR
|
|
|
|
| Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
| Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
| Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
| Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
| Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
| Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
| Myelodysplastic syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
| Myelodysplastic syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
| Myelodysplastic Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
| Myelodysplastic Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
| Myelodysplastic Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
| Myelodysplastic Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|FQR
|
|Complete
|Complete
|
|
|FQR
|
|
|
|
| Myelodysplastic Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
| Myelodysplastic Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
| Refractory Cytopenia of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
| Refractory Cytopenia of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|
|FQR
|
|PENDING
|PENDING
|
|
|FQR
|
|
|
|
|-
|-
| || ||
| || ||
|
|
|
|
|
| ||
|
|
|
|
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|
|Complete
|Complete
|
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|
|
|
|
|-
|-
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying Zou
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying Zou
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Acute Myeloid Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
| Acute Myeloid Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
|
|
|PENDING
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Myeloid Neoplasms with Germline DDX41 Mutation||Disease||Fei Yang
| Myeloid Neoplasms with Germline DDX41 Mutation||Disease||Fei Yang
|
|
|
|PENDING
| ||JH / MS
|
|
|
|
|-
|-
| Myeloid Neoplasms with Germline RUNX1 Mutation||Disease||Malini Sathanoori
| Myeloid Neoplasms with Germline RUNX1 Mutation||Disease||Malini Sathanoori
|
|
|PENDING
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Myeloid Neoplasms with Germline ANKRD26 Mutation||Disease||Fei Yang
| Myeloid Neoplasms with Germline ANKRD26 Mutation||Disease||Fei Yang
|
|
|PENDING
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Myeloid Neoplasms with Germline ETV6 Mutation||Disease||Ying Zou
| Myeloid Neoplasms with Germline ETV6 Mutation||Disease||Ying Zou
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Myeloid Neoplasms with Germline GATA2 Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
| Myeloid Neoplasms with Germline GATA2 Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
|
|
|JH / MS
|
|Complete
|Complete
|
|
|JH / MS
|
|
|
|
|-
|-
| Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
| Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
| Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Acute Promyelocytic Leukemia (APL) with PML-RARA||Disease||Shashi Shetty
| Acute Promyelocytic Leukemia (APL) with PML-RARA||Disease||Shashi Shetty
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
| Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
| Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
| Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|Need permission for figure? Update WHO?
|Need permission for figure? Update WHO?
|-
|-
| Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
| Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Acute Myeloid Leukemia (AML) with BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
| Acute Myeloid Leukemia (AML) with BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Acute Myeloid Leukemia (AML) with Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
| Acute Myeloid Leukemia (AML) with Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|Add WHO reference
|Add WHO reference
|-
|-
| Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg Conboy (Monash Health)
| Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg Conboy (Monash Health)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Acute Myeloid Leukemia (AML) with Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
| Acute Myeloid Leukemia (AML) with Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
|
|
|
|Complete
| ||JH / MS
|
|
|Check reference format
|Check reference format
|-
|-
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Acute Myeloid Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
| Acute Myeloid Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
| Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
| Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Acute Myelomonocytic Leukemia||Disease||Fei Yang
| Acute Myelomonocytic Leukemia||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
| Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Pure Erythroid Leukemia||Disease||Ash Yenamandra
| Pure Erythroid Leukemia||Disease||Ash Yenamandra
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
| Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Acute Basophilic Leukemia||Disease||Ash Yenamandra
| Acute Basophilic Leukemia||Disease||Ash Yenamandra
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
| Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty Greipp
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty Greipp
|
|
|
|Complete
| ||JH / MS
|
|
|Need permission for figure?
|Need permission for figure?
|-
|-
| Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome||Disease||Linda Cooley
| Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome||Disease||Linda Cooley
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Myeloid Leukemia Associated with Down Syndrome||Disease||Linda Cooley
| Myeloid Leukemia Associated with Down Syndrome||Disease||Linda Cooley
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Acute Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
| Acute Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|Check reference format
|Check reference format
|-
|-
| Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
| Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
| Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
| Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|Check reference format
|Check reference format
|-
|-
| Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
| Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
|
|
|Complete
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| ??Mixed-Phenotype Acute Leukaemia, Not Otherwise Specified (NOS), Rare Types||Disease||
| ??Mixed-Phenotype Acute Leukaemia, Not Otherwise Specified (NOS), Rare Types||Disease||
|
|
|??
| ||JH / MS
| ||JH / MS
|
|
|
|
|-
|-
| ??Acute Leukaemias of Ambiguous Lineage, Not Otherwise Specified (NOS)||Disease||
| ??Acute Leukaemias of Ambiguous Lineage, Not Otherwise Specified (NOS)||Disease||
|
|
|??
| ||JH / MS
| ||JH / MS
|
|
|
|
|Kay Weng Choy + Greg Conboy (Monash Health)
|Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|JH / MS
|
|Complete
|Complete
|
|
|JH / MS
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
|Daynna Wolff+Jessica Snider (Path Resident)
|Daynna Wolff+Jessica Snider (Path Resident)
|
|
|JH / MS
|
|PENDING
|PENDING
|
|
|JH / MS
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
|Daynna Wolff+ Paige Woodham (Path Resident)
|Daynna Wolff+ Paige Woodham (Path Resident)
|
|
|JH / MS
|
|PENDING
|PENDING
|
|
|JH / MS
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
| || ||
| || ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
| ||Yassmine Akkari (YA)
|
|
|
|
|-
|-
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities'''''||'''''Overview'''''||
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities'''''||'''''Overview'''''||
|
|
|
|
|
| ||YA
|
|
|
|
|-
|-
| B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 ||Disease||
| B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 ||Disease||
|
|
|
|
|
| ||YA
|
|
|
|
| B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
| B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
|
|
|YA
|
|PENDING
|PENDING
|
|
|YA
|
|
|
|
|-
|-
| B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||
| B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||
|
|
|
|
|
| ||YA
|
|
|
|
|-
|-
| B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy||Disease||
| B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy||Disease||
|
|
|
|
|
| ||YA
|
|
|
|
Lisa Smith + Yassmine Akkari
Lisa Smith + Yassmine Akkari
|
|
|YA
|
|Complete
|Complete
|
|
|YA
|
|
|
|
|-
|-
| B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3||Disease||
| B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3||Disease||
|
|
|
|
|
| ||YA
|
|
|
|
|-
|-
| B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1||Disease||
| B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1||Disease||
|
|
|
|
|
| ||YA
|
|
|
|
| B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
| B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|
|
|YA
|
|Complete
|Complete
|
|
|YA
|
|
|
|
|-
|-
| B-Lymphoblastic Leukemia/Lymphoma with iAMP21||Disease||
| B-Lymphoblastic Leukemia/Lymphoma with iAMP21||Disease||
|
|
|
|
|
| ||YA
|
|
|
|
|-
|-
| B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified||Disease||
| B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified||Disease||
|
|
|
|
|
| ||YA
|
|
|
|
|-
|-
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||
|
|
|
|
|
| ||YA
|
|
|
|
|-
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||
|
|
|
|
|
| ||YA
|
|
|
|
|-
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||
|
|
|
|
|
| ||YA
|
|
|
|
|Helene Bruyere
|Helene Bruyere
|
|
|YA
|
|PENDING
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
| || ||
| || ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
| ||Snehal Patel (SP)
|
|
|
|
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
| Monoclonal B-cell Lymphocytosis||Disease||Honey Reddi
| Monoclonal B-cell Lymphocytosis||Disease||Honey Reddi
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|B-cell Prolymphocytic Leukemia||Disease||Honey Reddi
|B-cell Prolymphocytic Leukemia||Disease||Honey Reddi
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|
|
|SP
|
|Complete
|Complete
|
|
|SP
|
|
|Malini to review
|Malini to review
|Hairy Cell Leukemia||Disease||Snehal Patel
|Hairy Cell Leukemia||Disease||Snehal Patel
|
|
|SP
|
|Complete
|Complete
|
|
|SP
|
|
|Malini to review
|Malini to review
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|
|
|SP
|
|Complete
|Complete
|
|
|SP
|
|
|Malini to review
|Malini to review
| Splenic Diffuse Red Pulp Small B-cell Lymphoma||Disease||Snehal Patel
| Splenic Diffuse Red Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|
|
|SP
|
|Complete
|Complete
|
|
|SP
|
|
|Malini to review
|Malini to review
| Hairy Cell Leukemia Variant||Disease||Snehal Patel
| Hairy Cell Leukemia Variant||Disease||Snehal Patel
|
|
|SP
|
|Complete
|Complete
|
|
|SP
|
|
|Malini to review
|Malini to review
|Lymphoplasmacytic Lymphoma||Disease||Honey Reddi
|Lymphoplasmacytic Lymphoma||Disease||Honey Reddi
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
| Waldenstrom Macroglobulinemia||Disease||Honey Reddi
| Waldenstrom Macroglobulinemia||Disease||Honey Reddi
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
| Mu Heavy Chain Disease||Disease||
| Mu Heavy Chain Disease||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
| Gamma Heavy Chain Disease||Disease||
| Gamma Heavy Chain Disease||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
| Alpha Heavy Chain Disease||Disease||
| Alpha Heavy Chain Disease||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
| Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease||Zhenya Tang
| Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
| Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
| Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
| Plasma Cell Myeloma Variants||Disease||Zhenya Tang
| Plasma Cell Myeloma Variants||Disease||Zhenya Tang
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
| Plasmacytoma||Disease||Zhenya Tang
| Plasmacytoma||Disease||Zhenya Tang
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|''''' Monoclonal Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|''''' Monoclonal Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
| Primary Amyloidosis||Disease||
| Primary Amyloidosis||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
| Light Chain and Heavy Chain Deposition Disease||Disease||
| Light Chain and Heavy Chain Deposition Disease||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
| POEMS Syndrome||Disease||
| POEMS Syndrome||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
| TEMPI Syndrome||Disease||
| TEMPI Syndrome||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|Nodal Marginal Zone Lymphoma||Disease||
|Nodal Marginal Zone Lymphoma||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
| Paediatric Nodal Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
| Paediatric Nodal Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|Follicular Lymphoma||Disease||Ruthann Pfau
|Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
| Testicular Follicular Lymphoma||Disease||Ruthann Pfau
| Testicular Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
| In Situ Follicular Neoplasia||Disease||Ruthann Pfau
| In Situ Follicular Neoplasia||Disease||Ruthann Pfau
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
| Duodenal-Type Follicular Lymphoma||Disease||Ruthann Pfau
| Duodenal-Type Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|Primary Cutaneous Follicle Centre Lymphoma||Disease||
|Primary Cutaneous Follicle Centre Lymphoma||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|
|
|SP
|
|PENDING - due 8/15/20
|PENDING - due 8/15/20
|
|
|SP
|
|
|
|
| Leukemic Non-Nodal Mantle Cell Lymphoma||Disease||Mahsa Khanlari
| Leukemic Non-Nodal Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|
|
|SP
|
|PENDING - due 8/31/20
|PENDING - due 8/31/20
|
|
|SP
|
|
|
|
| In Situ Mantle Cell Neoplasia||Disease||Mahsa Khanlari
| In Situ Mantle Cell Neoplasia||Disease||Mahsa Khanlari
|
|
|SP
|
|PENDING - due 8/15/20
|PENDING - due 8/15/20
|
|
|SP
|
|
|
|
|-
|-
| || ||
| || ||
|
|
|
|
|
| ||
|
|
|
|
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
|
|
|Greg Corboy (GC)
|
|PENDING
|PENDING
|
|
|Greg Corboy (GC)
|
|
|
|
|-
|-
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|EBV-Positive Mucocutaneous Ulcer||Disease||
|EBV-Positive Mucocutaneous Ulcer||Disease||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation||Disease||
|Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation||Disease||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| Fibrin-Associated Diffuse Large B-cell Lymphoma||Disease||
| Fibrin-Associated Diffuse Large B-cell Lymphoma||Disease||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Lymphomatoid Granulomatosis||Disease||
|Lymphomatoid Granulomatosis||Disease||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Intravascular Large B-cell Lymphoma||Disease||
|Intravascular Large B-cell Lymphoma||Disease||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|ALK-Positive Large B-cell Lymphoma||Disease||
|ALK-Positive Large B-cell Lymphoma||Disease||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|Complete
| ||GC
| ||GC
|
|
|
|
|-
|-
|Primary Effusion Lymphoma||Disease||
|Primary Effusion Lymphoma||Disease||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| Multicentric Castleman Disease||Disease||
| Multicentric Castleman Disease||Disease||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
| HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| HHV8-Positive Germinotropic Lymphoproliferative Disorder||Disease||
| HHV8-Positive Germinotropic Lymphoproliferative Disorder||Disease||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Burkitt Lymphoma||Disease||
|Burkitt Lymphoma||Disease||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
| High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
| High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| || ||
| || ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
| ||Snehal Patel (SP)
|
|
|
|
|-
|-
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|Aggressive NK-cell Leukemia||Disease||
|Aggressive NK-cell Leukemia||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood'''''||'''''Overview'''''||
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood'''''||'''''Overview'''''||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
| Systemic EBV-Positive T-cell Lymphoma of Childhood||Disease||
| Systemic EBV-Positive T-cell Lymphoma of Childhood||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
| Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form||Disease||
| Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
| Hydroa Vacciniforme-Like Lymphoproliferative Disorder||Disease||
| Hydroa Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
| Severe Mosquito Bite Allergy||Disease||
| Severe Mosquito Bite Allergy||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|Adult T-cell Leukemia/Lymphoma||Disease||
|Adult T-cell Leukemia/Lymphoma||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
| Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
| Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
| Monomorphic Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
| Monomorphic Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
| Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
| Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
| Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
| Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|Mycosis Fungoides||Disease||
|Mycosis Fungoides||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|Sézary Syndrome||Disease||
|Sézary Syndrome||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders'''''||'''''Overview'''''||
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
| Lymphomatoid Papulosis||Disease||
| Lymphomatoid Papulosis||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
| Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease||
| Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
| Primary Cutaneous Gamma Delta T-cell Lymphoma||Disease||
| Primary Cutaneous Gamma Delta T-cell Lymphoma||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
| Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
| Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
| Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease||
| Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
| Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
| Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|
|
|
|
|
| ||SP
|
|
|
|
| Angioimmunoblastic T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
| Angioimmunoblastic T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
| Follicular T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
| Follicular T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|-
|-
| Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype||Disease||
| Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype||Disease||
|
|
|
|
|
| ||SP
|
|
|
|
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|
|
|SP
|
|PENDING
|PENDING
|
|
|SP
|
|
|
|
|-
|-
| || ||
| || ||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|
|
|
|
|
| ||Associate Editor??
|
|
|
|
|-
|-
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
| Nodular Sclerosis Classic Hodgkin Lymphoma||Disease||
| Nodular Sclerosis Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
| Lymphocyte-Rich Classic Hodgkin Lymphoma||Disease||
| Lymphocyte-Rich Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
| Mixed Cellularity Classic Hodgkin Lymphoma||Disease||
| Mixed Cellularity Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
| Lymphocyte-Depleted Classic Hodgkin Lymphoma||Disease||
| Lymphocyte-Depleted Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Lymphomas Associated with HIV Infection||Disease||
|Lymphomas Associated with HIV Infection||Disease||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
| Non-Destructive Post-Transplant Lymphoproliferative Disorders||Disease||
| Non-Destructive Post-Transplant Lymphoproliferative Disorders||Disease||
|
|
|
|
|
| ||
|
|
|
|
|
|
|PENDING
|PENDING
|
|
|
|
|
|-
|-
|''''' Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|''''' Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
| Monomorphic B-cell PTLD||Disease||
| Monomorphic B-cell PTLD||Disease||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
| Monomorphic T/NK-cell PTLD||Disease||
| Monomorphic T/NK-cell PTLD||Disease||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
| Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
| Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders||Disease||
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders||Disease||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Histiocytic Sarcoma||Disease||
|Histiocytic Sarcoma||Disease||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
| Langerhans Cell Histiocytosis||Disease||
| Langerhans Cell Histiocytosis||Disease||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
| Langerhans Cell Sarcoma||Disease||
| Langerhans Cell Sarcoma||Disease||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Indeterminate Dendritic Cell Tumour||Disease||
|Indeterminate Dendritic Cell Tumour||Disease||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Interdigitating Dendritic Cell Sarcoma||Disease||
|Interdigitating Dendritic Cell Sarcoma||Disease||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Follicular Dendritic Cell Sarcoma||Disease||
|Follicular Dendritic Cell Sarcoma||Disease||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
| Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
| Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|Fibroblastic Reticular Cell Tumor||Disease||
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|Disseminated Juvenile Xanthogranuloma||Disease||
|
|
|
| ||
| ||
|
|
|
|
|-
|Erdheim-Chester Disease||Disease||
|
|
|
| ||
|
|
|
|
|-
|-
|Erdheim-Chester Disease||Disease||
| || ||
|
|
|
| ||
| ||
|
|
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
| || ||
| || ||
|
|
|
|
|
|
| ||
| ||
|
|
|
|
|-
|-
| || ||
| || ||
|
|
|
|
|
|
| ||
| ||
|
|
|
|
|-
|-
| || ||
| || ||
|
|
|
|
|
|
| ||
| ||
|
|
|
|
|-
|-
| || ||
| || ||
|
|
|
|
|
|
| ||
| ||
|
|
|
|
|-
|-
| || ||
| || ||
|
|
|
|
|
|
| ||
| ||
|
|
|
|
|-
|-
| || ||
| || ||
|
|
|
|
|
|
| ||
| ||
|
|
|
|
|-
|-
| || ||
| || ||
|
|
|
|
|
|
| ||
| ||
|
|
|
|
|-
|-
| || ||
| || ||
|
|
|
|
|
|
| ||
| ||
|
|
|
|
|-
|-
| || ||
| || ||
|
|
|
|
|
|
| ||
| ||
|
|
|
|
|-
|-
| || ||
| || ||
|
|
|
|
|
|
| ||
| ||
|
|
|
|